STUDY SEARCH RESULTS

1 study found for your search request:  6194-007

A clinical study of MK-6194 for the treatment of vitiligo (MK-6194-007)
Condition: Non-segmental vitiligo
Minimum Age: 18 years, Maximum Age: 75 years
Gender: All
Study ID: NCT06113328
Status: Recruiting
Has Enrolling Locations in US or Canada




Copyright © 2024 · Merck & Co., Inc., Rahway, NJ, USA, and its affiliates. All rights reserved. · This site is intended only for residents of the United States.
Cookie Preferences  Privacy  Terms of Use  U.S. Corporate Site